Brief: US FDA Approves Agios’ Aqvesme (Mitapivat) For Treatment Of Anemia In Adults With Alpha- Or Beta-Thalassemia

Agios Pharmaceuticals

24/12/2025 24:57

Dec 24 (Reuters) - Agios Pharmaceuticals Inc AGIO.O:

U.S. FDA APPROVES AGIOS’ AQVESME (MITAPIVAT) FOR THE TREATMENT OF ANEMIA IN ADULTS WITH ALPHA- OR BETA-THALASSEMIA

AGIOS PHARMACEUTICALS INC - AQVESME EXPECTED TO BE AVAILABLE IN LATE JANUARY 2026

Source text: ID:nGNX3lHMnZ

Further company coverage: AGIO.O

 ((reuters.briefs@thomsonreuters.com;))